These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15817992)

  • 1. DOTS in pediatric patients.
    Joshi V
    Indian Pediatr; 2005 Mar; 42(3):299; author reply 299-300. PubMed ID: 15817992
    [No Abstract]   [Full Text] [Related]  

  • 2. Status report on DOTS expansion and implementation during the 2nd quarter 2004 (April-June 2004).
    Chauhan LS
    J Indian Med Assoc; 2004 Nov; 102(11):627-8. PubMed ID: 15868873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trend in the prevalence of TB infection and ARTI after implementation of a DOTS programme in south India.
    Gopi PG; Subramani R; Narayanan PR
    Int J Tuberc Lung Dis; 2006 Mar; 10(3):346-8. PubMed ID: 16562719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Status report on DOTS expansion and implementation during the 4th quarter 2003.
    Chauhan LS
    J Indian Med Assoc; 2004 May; 102(5):256-7, 281. PubMed ID: 15636028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DOTS and DOTS plus: what's in a name.
    Aerts A; de Haller R
    Int J Tuberc Lung Dis; 2001 Sep; 5(9):879-80. PubMed ID: 11573904
    [No Abstract]   [Full Text] [Related]  

  • 6. The slippery slope to sloppy DOTS.
    Frieden T; Sbarbaro JA
    Int J Tuberc Lung Dis; 2002 May; 6(5):371-2. PubMed ID: 12019910
    [No Abstract]   [Full Text] [Related]  

  • 7. DOTS and DOTS-plus in Hong Kong.
    Yew WW; Tam CM
    Int J Tuberc Lung Dis; 2003 Jan; 7(1):99-100. PubMed ID: 12701843
    [No Abstract]   [Full Text] [Related]  

  • 8. An expanded DOTS framework for effective tuberculosis control.
    Int J Tuberc Lung Dis; 2002 May; 6(5):378-88. PubMed ID: 12019913
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of pediatric tuberculosis in the year 2000.
    Bisca N
    Pediatr Pulmonol; 2001; Suppl 23():65-6. PubMed ID: 11886152
    [No Abstract]   [Full Text] [Related]  

  • 10. DOTS-S: directly observed therapy short course-with smiles.
    Baum GL; Lafair J
    Int J Tuberc Lung Dis; 2003 Feb; 7(2):200-1. PubMed ID: 12588027
    [No Abstract]   [Full Text] [Related]  

  • 11. Tuberculosis deaths averted by implementation of the DOTS strategy in Kazakhstan.
    Favorov M; Belilovsky E; Aitmagambetova I; Ismailov S; White ME; Chorba T
    Int J Tuberc Lung Dis; 2010 Dec; 14(12):1582-8. PubMed ID: 21144244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Revised National Tuberculosis Control Programme in India: time for revision of treatment regimens and rapid upscaling of DOTS-plus initiative.
    Bhargava A; Jain Y
    Natl Med J India; 2008; 21(4):187-91. PubMed ID: 19267041
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment outcome of neuro tuberculosis patients put on DOTS--an observation study from the field.
    Venugopal K; Sreelatha PR; Philip S; Kumar V
    Indian J Tuberc; 2008 Oct; 55(4):199-202. PubMed ID: 19295107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Issues in pediatric tuberculosis under DOTS strategy.
    Arora VK
    Indian Pediatr; 2004 Sep; 41(9):891-3. PubMed ID: 15475629
    [No Abstract]   [Full Text] [Related]  

  • 15. Paediatric tuberculosis and DOTS strategy under RNTCP.
    Chugh S
    J Indian Med Assoc; 2008 Dec; 106(12):799-802. PubMed ID: 19370953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TB prevalence down 30% in China after DOTS.
    Bull World Health Organ; 2004 Sep; 82(9):716. PubMed ID: 15628214
    [No Abstract]   [Full Text] [Related]  

  • 17. Status report on RNTCP.
    Chauhan LS
    Indian J Tuberc; 2009 Jan; 56(1):44-7. PubMed ID: 19402271
    [No Abstract]   [Full Text] [Related]  

  • 18. Compliance with DOTS diagnosis and treatment recommendations by private practitioners in Kerala, India.
    Greaves F; Ouyang H; Pefole M; MacCarthy S; Cash RA
    Int J Tuberc Lung Dis; 2007 Jan; 11(1):110-2. PubMed ID: 17217139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse drug reactions observed during DOTS.
    Dhingra VK; Rajpal S; Aggarwal N; Aggarwaln JK; Shadab K; Jain SK
    J Commun Dis; 2004 Dec; 36(4):251-9. PubMed ID: 16506547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DOTS in HIV positive patients.
    Bedi RS
    Indian J Tuberc; 2008 Oct; 55(4):229. PubMed ID: 19295114
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.